AT366361B - Verfahren zur herstellung neuer 2-aminotetraline - Google Patents

Verfahren zur herstellung neuer 2-aminotetraline

Info

Publication number
AT366361B
AT366361B AT0871977A AT871977A AT366361B AT 366361 B AT366361 B AT 366361B AT 0871977 A AT0871977 A AT 0871977A AT 871977 A AT871977 A AT 871977A AT 366361 B AT366361 B AT 366361B
Authority
AT
Austria
Prior art keywords
aminotetraline
producing new
producing
new
Prior art date
Application number
AT0871977A
Other languages
German (de)
English (en)
Other versions
ATA871977A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT0590179A priority Critical patent/AT365558B/de
Priority to AT590279A priority patent/AT370409B/de
Publication of ATA871977A publication Critical patent/ATA871977A/de
Application granted granted Critical
Publication of AT366361B publication Critical patent/AT366361B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
AT0871977A 1976-12-07 1977-12-06 Verfahren zur herstellung neuer 2-aminotetraline AT366361B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0590179A AT365558B (de) 1977-12-06 1977-12-06 Verfahren zur herstellung neuer 2-aminotetraline
AT590279A AT370409B (de) 1976-12-07 1979-09-07 Verfahren zur herstellung neuer 2-aminotetraline

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (2)

Publication Number Publication Date
ATA871977A ATA871977A (de) 1981-08-15
AT366361B true AT366361B (de) 1982-04-13

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0871977A AT366361B (de) 1976-12-07 1977-12-06 Verfahren zur herstellung neuer 2-aminotetraline

Country Status (17)

Country Link
JP (1) JPS5384955A (xx)
AT (1) AT366361B (xx)
CA (1) CA1105475A (xx)
DE (1) DE2752659A1 (xx)
DK (1) DK527877A (xx)
ES (1) ES464747A1 (xx)
FI (1) FI773595A (xx)
FR (1) FR2373513A1 (xx)
GB (1) GB1597140A (xx)
IE (1) IE45929B1 (xx)
IL (1) IL53533A (xx)
NL (1) NL7713364A (xx)
NZ (1) NZ185884A (xx)
PH (1) PH13932A (xx)
PT (1) PT67365B (xx)
SE (1) SE7713471L (xx)
SU (1) SU927110A3 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
JPS639500B2 (xx) * 1978-07-14 1988-02-29 Amerikan Hosupitaru Sapurai Corp
DE3062971D1 (en) 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
EP0033789B1 (en) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
AU8455082A (en) * 1981-05-11 1982-12-07 Folk Lars-Erik Arvidsson Therapeutically useful tetralin derivatives iii,processes forpreparation and pharmaceutical preparations for such compounds
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
US5380748A (en) * 1991-03-07 1995-01-10 Zeria Pharmaceutical Co., Ltd. Trialkylamine derivative and ameliorant for digestive tract movement containing the same
DE69724259T2 (de) * 1996-05-31 2004-06-09 Pharmacia & Upjohn Co., Kalamazoo Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
ES2626024T3 (es) * 2011-06-27 2017-07-21 Shan Dong Luye Pharmaceutical Co., Ltd. Procedimiento para preparar industrialmente amino-5,6,7,8-tetrahidronaftol sustituido con nitrógeno

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols

Also Published As

Publication number Publication date
ATA871977A (de) 1981-08-15
PT67365A (fr) 1978-01-01
JPS5384955A (en) 1978-07-26
SE7713471L (sv) 1978-06-08
IL53533A (en) 1982-07-30
FR2373513B1 (xx) 1980-08-22
IL53533A0 (en) 1978-03-10
ES464747A1 (es) 1979-01-01
DK527877A (da) 1978-06-08
FI773595A (fi) 1978-06-08
PH13932A (en) 1980-11-04
NZ185884A (en) 1980-04-28
DE2752659A1 (de) 1978-06-08
IE45929B1 (en) 1982-12-29
NL7713364A (nl) 1978-06-09
JPS6214540B2 (xx) 1987-04-02
SU927110A3 (ru) 1982-05-07
GB1597140A (en) 1981-09-03
CA1105475A (en) 1981-07-21
PT67365B (fr) 1979-09-20
IE45929L (en) 1978-06-07
FR2373513A1 (fr) 1978-07-07

Similar Documents

Publication Publication Date Title
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362363B (de) Verfahren zur herstellung neuer azetidinole
AT371139B (de) Verfahren zur herstellung neuer bitumenzusammen- setzungen
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
DD134641A5 (de) Verfahren zur herstellung neuer sulfamoylbenzoesaeuren
AT355036B (de) Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one
AT351673B (de) Verfahren zur herstellung neuer antibiotika
AT351046B (de) Verfahren zur herstellung neuer diharnstoffe
AT360971B (de) Verfahren zur herstellung neuer alkinole
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
AT348162B (de) Verfahren zur herstellung neuer d-homosteroide
AT355239B (de) Verfahren zur herstellung neuer d-homosteroide
ATA590279A (de) Verfahren zur herstellung neuer 2-aminotetraline
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
AT350528B (de) Verfahren zur herstellung neuer fluoracylresorcine

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee